A gene-editing toolkit shaping biology and medicine
Anthropic is launching an internal drug-discovery program to develop AI tools for life sciences, focusing on neglected diseases. The effort aims to create drug-discovery capabilities in-house and partner with industry, while navigating the costly regulatory path and uncertain clinical development timelines.
Researchers have used CRISPR to edit dogs’ genes, producing two hypoallergenic beagles. The dogs’ saliva and fur no longer carry the allergy-causing protein, offering hope to millions with dog allergies. Commercial availability remains years away as health, ethical, and adoption considerations are debated.